Stool sample analysis (stool lab) is offered by MyBody-X as part of health check-ups to provide insights into gut health, microbiome composition, inflammation markers (e.g., calprotectin), and digestive function. However, the provided knowledge contexts contain no specific studies or markers for stool diagnostics – they focus on genetic variants (MTHFR, MC4R, APOA5) and signaling pathways (mTOR/AMPK). Therefore, this answer is based on general practice: stool tests can be useful for detecting dysbiosis or inflammatory bowel conditions, but the evidence for actionable recommendations from consumer tests is weak. Many offered parameters (e.g., microbiome diversity) lack standardization and clinically validated reference ranges. Moreover, longitudinal data demonstrating a causal link between stool findings and health outcomes are missing. MyBody-X should clearly communicate that results are exploratory and not a substitute for medical diagnosis. An elevated calprotectin level may indicate inflammation but requires medical follow-up. Overall, the utility of stool tests in the consumer space is currently rated as 'practice' (common but limited evidence). Safety note: Always consult a physician for persistent symptoms.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-d8ff46f46d77a69fc879ec56